Bridgebio Pharma, Inc.
Could not find a ticker for this position, may be a filing error
A biopharmaceutical company developing medicines for genetic diseases, BridgeBio's approved products include Attruby for a heart condition called ATTR-CM and Truseltiq for bile-duct cancer. Founded in 2015, its name reflects a mission of 'bridging' genetic research to patients, and it runs a hub-and-spoke model where small teams advance each drug. Its experimental oral therapy for achondroplasia was the first-ever treatment for children with the condition to earn the FDA's Breakthrough Therapy designation.
2.25% Convertible Senior Notes due 2029
Sold 5.84M
Bought 2.65M
Bought 4.71M
Sold 8.07M
Sold 17.80M
Bought 4.71M
Granted 10.30M · Sold 4.06M
Granted 1.43M · Sold 449.5K
Granted 1.49M · Sold 674.0K
Granted 237.1K · Sold 103.8K
Granted 381.3K · Bought 7.0K · Sold 103.8K
Granted 170.0K
Granted 10.6K · Bought 7.5K · Sold 195.6K
Granted 37.8K · Sold 8.5K
Granted 800.9K · Bought 63.5K · Sold 584.1K
Granted 19.1K · Bought 80.0K
Granted 219.3K · Sold 160.6K
Granted 10.6K · Bought 20.0K
Granted 10.6K · Bought 19.3K
Granted 138.0K · Sold 129.6K
Granted 24.4K
Granted 132.7K · Bought 12.0K · Sold 122.1K
Granted 71.6K · Bought 22.1K · Sold 72.8K
Granted 101.9K · Bought 7.5K · Sold 98.2K
Granted 95.9K · Sold 83.3K
Granted 36.6K · Bought 16.0K · Sold 42.0K
Bought 17.6K
Granted 2.5K · Bought 14.0K
Granted 10.6K
Granted 5.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| KKR & Co. Inc. +7 co-filers10% owner · 2 transactions | — | 65.57Mas of Feb 2021 | — | — | 5.84M |
| KKR & Co. Inc. +8 co-filers10% owner · 2 transactions | — | 34.25Mas of Jul 2019 | — | 2.65M | — |
| Halvorsen Ole Andreas +6 co-filers10% owner · 3 transactions | — | 21.92Mas of Jun 2019 | — | 4.71M | — |
| Halvorsen Ole Andreas +7 co-filers10% owner · 3 transactions | — | 18.56Mas of Jun 2025 | — | — | 8.07M |
| KKR & Co. Inc. +8 co-filers10% owner · 3 transactions | — | 13.26Mas of May 2025 | — | — | 17.80M |
| Halvorsen Ole Andreas +6 co-filers10% owner · 3 transactions | — | 11.74Mas of Jun 2019 | — | 4.71M | — |
| Kumar NeilChief Executive Officer, Director · 278 transactions | — | 5.09M | 10.30M | — | 4.06M |
| Homcy Charles JDirector · 42 transactions | — | 919.9K | 1.43M | — | 449.5K |
| McCormick FrankDirector · 35 transactions | — | 767.2K | 1.49M | — | 674.0K |
| Trimarchi ThomasPresident and CFO · 22 transactions | — | 359.2K | 237.1K | — | 103.8K |
| Henderson Michael ThomasChief Business Officer · 56 transactions | — | 274.2Kas of Dec 2020 | 381.3K | 7.0K | 103.8K |
| Satvat Ali J.Director · 5 transactions | — | 170.0K | 170.0K | — | — |
| Lo AndrewDirector · 9 transactions | — | 164.3K | 10.6K | 7.5K | 195.6K |
| Apuli MaricelChief Accounting Officer · 14 transactions | — | 129.4K | 37.8K | — | 8.5K |
| Stephenson Brian CCFO and Treasurer · 91 transactions | — | 111.0Kas of Feb 2025 | 800.9K | 63.5K | 584.1K |
| Momtazee James CDirector · 4 transactions | — | 99.1K | 19.1K | 80.0K | — |
| Scheller Richard HDirector · 23 transactions | — | 53.8Kas of Feb 2023 | 219.3K | — | 160.6K |
| Dachille Douglas A.Director · 5 transactions | — | 30.6K | 10.6K | 20.0K | — |
| Hassan FredDirector · 3 transactions | — | 29.9K | 10.6K | 19.3K | — |
| Cook Jennifer E.Director · 12 transactions | — | 28.4K | 138.0K | — | 129.6K |
| Stolz Brian M.Chief Operating Officer · 3 transactions | — | 24.6Kas of Aug 2020 | 24.4K | — | — |
| Ellis AndreaDirector · 11 transactions | — | 22.6K | 132.7K | 12.0K | 122.1K |
| Daniels Ronald JDirector · 7 transactions | — | 21.0K | 71.6K | 22.1K | 72.8K |
| Valantine HannahDirector · 33 transactions | — | 21.0K | 101.9K | 7.5K | 98.2K |
| Turtle CameronSee Remarks · 38 transactions | — | 20.1Kas of Dec 2020 | 95.9K | — | 83.3K |
| Scott Randal W.Director · 22 transactions | — | 19.4K | 36.6K | 16.0K | 42.0K |
| Saunders Brent LDirector · 1 transaction | — | 17.6Kas of Dec 2021 | — | 17.6K | — |
| Sinha UmaChief Scientific Officer · 4 transactions | — | 16.5Kas of Nov 2020 | 2.5K | 14.0K | — |
| Aguiar EricDirector · 2 transactions | — | 10.6K | 10.6K | — | — |
| Yau Yi ChingChief Accounting Officer · 4 transactions | — | 6.5Kas of Nov 2020 | 5.9K | — | — |
| KKR Management Holdings Corp +1 co-filer10% owner · 1 transaction | — | 0as of Jan 2020 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -26.25M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.